Update: US FDA nod for Aurobindo''s Lisinopril & Hydrochlorothiazide tabs

Aurobindo Pharma Ltd has announced that the US FDA has approved its Lisinopril and Hydrochlorothiazide tablets, 10 / 12.5mg, 20 / 12.5mg, and 20 / 25mg.

Lisinopril and Hydrochlorothiazide tablets, 10 / 12.5mg, 20 / 12.5mg, and 20 / 25mg is the generic version of Merck Research Laboratories'' Prinzide Tablets, 10 / 12.5 mg, 20 / 12.5mg, and 20 / 25mg.

The market opportunity for the above product is around $100 million. With this approval Aurbindo''s product basket for the US market has gone to 11.

This combination belongs to the class of medicines called antihypertensives (high blood pressure medicines).